New Inhibitors of Indoleamine 2,3-Dioxygenase 1: Molecular Modeling Studies, Synthesis, and Biological Evaluation-Reference-Cited by-同舟云学术

New Inhibitors of Indoleamine 2,3-Dioxygenase 1: Molecular Modeling Studies, Synthesis, and Biological Evaluation

Published:2016-10-26 Issue:21 Volume:59 Page:9760-9773
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Coluccia Antonio,Passacantilli Sara,Famiglini Valeria,Sabatino Manuela,Patsilinakos Alexandros¹,Ragno Rino¹,Mazzoccoli Carmela²,Sisinni Lorenza²,Okuno Alato³,Takikawa Osamu³,Silvestri Romano,La Regina Giuseppe

Affiliation:

1. Alchemical Dynamics s.r.l., Piazzale Aldo Moro 5, I-00185 Rome, Italy

2. Laboratorio di Ricerca Pre-Clinica e Traslazionale, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Centro di Riferimento Oncologico della Basilicata (CROB), Via Padre Pio 1, I-85028 Rionero in Vulture, Italy

3. National Institute for Longevity Sciences, National Center for Geriatrics and Gerontology 35 Gengo, Morioka, Obu, Aichi 474-8511, Japan

Funder

Sapienza Università di Roma

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.6b00718

Reference75 articles.

1. Tryptophan degradation in mice initiated by indoleamine 2,3-dioxygenase.

2. Aryl hydrocarbon receptor control of a disease tolerance defence pathway